Variables | PCC-1 n = 978 | PCC-2 n = 1,486 | PCC-3 n = 902 | PCC-4 n = 774 | p |
---|---|---|---|---|---|
CVD (events, %) | 22.2 | 20.7 | 20.0 | 21.1 | ns |
Use of ASA (%) | 29.1 | 35.3 | 20.0 | 28.2 | 0.000 |
Sex (males, %) | 46.9 | 51.5 | 46.8 | 50.9 | 0.041 |
Mean age (SD), years | 62.2 (14.2) | 64.1 (13.5) | 65.5 (13.5) | 64.9 (13.9) | 0.000 |
CV history | |||||
Hypertension | 49.4 | 51.2 | 55.8 | 50.0 | 0.002 |
Hypercholesterolemia | 35.8 | 39.5 | 37.7 | 36.2 | ns |
Active smoking | 21.6 | 17.7 | 18.3 | 17.2 | ns |
Obesity (BMI < 29) | 48.5 | 46.9 | 46.4 | 43.9 | ns |
Therapeutic targets | |||||
BP (<130/80 mmHg) | 49.6 | 37.4 | 50.1 | 57.6 | 0.002 |
Total cholesterol (<200 mg/dL) | 50.6 | 50.7 | 41.1 | 45.0 | 0.000 |
LDL-C (<100 mg/dL) | 20.6 | 21.7 | 13.5 | 17.1 | 0.000 |
Glycated HbA1c (<6.5%) | 33.3 | 34.4 | 32.0 | 33.6 | ns |